Dear colleagues: Welcome to the March 2018 issue of The Journal of Clinical and Aesthetic Dermatology (JCAD). We start this issue with a study titled “Double-blind, Placebo-controlled Trial to Evaluate
by Linda S. Marcus, MD Dr. Marcus is the Director of Dermatology Valley Hospital in Ridgewood, New Jersey. Funding/financial disclosures: The author has no conflicts of interest relevant to the content of
by Chee-Leok Goh, MD, MBBS, MRCP(UK), MMed(Int Med); Sai Yee Chuah, MBChB (Glasgow), MRCP(UK), Dip Derm, MRCPS (Glasgow); Steven Tien, MD; Guan Thng, MBBS, MRCP; María Alejandra Vitale, MD; and
by Esther RoE, PhD; Esther Serra, PhD; German Guzman, PhD; and Ignacio Sajoux, PhD Drs. Roe and Serra are with the Dermatology Department at the Hospital de la Santa Creu
by Rebecca F. Wang, BA; Myron Zhang, MD; Allireza Alloo, MD; Thomas Stasko, MD; Jordan E. Miller, BA; and Jessica A. Kaffenberger, MD Ms. Wang and Drs. Zhang and Kaffenberger
